<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37015317</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-7035</ISSN><JournalIssue CitedMedium="Internet"><Volume>250</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical immunology (Orlando, Fla.)</Title><ISOAbbreviation>Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps.</ArticleTitle><Pagination><StartPage>109317</StartPage><MedlinePgn>109317</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2023.109317</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1521-6616(23)00096-7</ELocationID><Abstract><AbstractText>The receptor for advanced glycation end-products (RAGE) is a pattern recognition receptor that regulates inflammation, cell migration, and cell fate. Systemic lupus erythematosus (SLE) is a chronic multiorgan autoimmune disease. To understand the function of RAGE in SLE, we generated RAGE-deficient (Ager<sup>-/-</sup>) lupus-prone mice by backcrossing MRL/MpJ-Fas<sup>lpr</sup>/J (MRL-lpr) mice with Ager<sup>-/-</sup> C57BL/6 mice. In 18-week-old Ager<sup>-/-</sup> MRL-lpr, the weights of the spleen and lymph nodes, as well as the frequency of CD3<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> cells, were significantly decreased. Ager<sup>-/-</sup> MRL-lpr mice had significantly reduced urine albumin/creatinine ratios and markedly improved renal pathological scores. Moreover, neutrophil infiltration and neutrophil extracellular trap formation in the glomerulus were significantly reduced in Ager<sup>-/-</sup> MRL-lpr. Our study is the first to reveal that RAGE can have a pathologic role in immune cells, particularly neutrophils and T cells, in inflammatory tissues and suggests that the inhibition of RAGE may be a potential therapeutic strategy for SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Haruki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, USA. Electronic address: harukiw@okayama-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Masataka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asano</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiramatsu-Asano</LastName><ForeName>Sumie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohashi</LastName><ForeName>Keiji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeggar</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuyama</LastName><ForeName>Eri</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuyama</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunahori-Watanabe</LastName><ForeName>Katsue</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sada</LastName><ForeName>Ken-Ei</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Yoshinori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Yasuhiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Komatsu University, Komatsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Myoungsun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI135063</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Immunol</MedlineTA><NlmUniqueID>100883537</NlmUniqueID><ISSNLinking>1521-6616</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="N">Receptor for Advanced Glycation End Products</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015416" MajorTopicYN="N">Maillard Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">Neutrophil extracellular traps</Keyword><Keyword MajorTopicYN="N">RAGE</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Conflict of interest J.W. receives grant support from Astellas, Bayer, Chugai, Daiichi Sankyo, Kissei, Kyowa Hakko Kirin, MSD, Otsuka, Teijin, Torii, Pfizer, Takeda, and Taisho Toyama. Other authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37015317</ArticleId><ArticleId IdType="mid">NIHMS1890860</ArticleId><ArticleId IdType="pmc">PMC10234279</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2023.109317</ArticleId><ArticleId IdType="pii">S1521-6616(23)00096-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. The Journal of biological chemistry. 1992;267(21):14998&#x2013;5004.</Citation><ArticleIdList><ArticleId IdType="pubmed">1378843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan BH, Li X, Winkler AR, Cunningham KM, Kuai J, Greco RM, Nocka KH, Fitz LJ, Wright JF, Pittman DD, Tan XY, Paulsen JE, Lin LL, Winkler DG. Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-&#x3b1; production in a receptor for advanced glycation end product-dependent manner. J Immunol. 2010;185(7):4213&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20817881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97(7):889&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">10399917</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108(7):949&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC200958</ArticleId><ArticleId IdType="pubmed">11581294</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AM. 2016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage. Arterioscler Thromb Vasc Biol. 2017;37(4):613&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364055</ArticleId><ArticleId IdType="pubmed">28183700</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Son M. The Immune Tolerance Role of the HMGB1-RAGE Axis. Cells. 2021;10(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8001022</ArticleId><ArticleId IdType="pubmed">33807604</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 1993;143(6):1699&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887265</ArticleId><ArticleId IdType="pubmed">8256857</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D&#x2019;Agati VD. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol. 2000;11(9):1656&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">10966490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 2008;22(5):1572&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18089847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, Reinhart TA, Oury TD. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). The Journal of biological chemistry. 2004;279(48):50019&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868562</ArticleId><ArticleId IdType="pubmed">15381690</ArticleId></ArticleIdList></Reference><Reference><Citation>Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008;22(10):3716&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">18603587</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009;462(7269):99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">19890330</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nature reviews Rheumatology. 2012;8(4):195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">22293756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirois CM, Jin T, Miller AL, Bertheloot D, Nakamura H, Horvath GL, Mian A, Jiang J, Schrum J, Bossaller L, Pelka K, Garbi N, Brewah Y, Tian J, Chang C, Chowdhury PS, Sims GP, Kolbeck R, Coyle AJ, Humbles AA, Xiao TS, Latz E. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J Exp Med. 2013;210(11):2447&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3804942</ArticleId><ArticleId IdType="pubmed">24081950</ArticleId></ArticleIdList></Reference><Reference><Citation>Porat A, Giat E, Kowal C, He M, Son M, Latz E, Ben-Zvi I, Al-Abed Y, Diamond B. DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways. Front Immunol. 2018;9:2824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297782</ArticleId><ArticleId IdType="pubmed">30619247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">17417641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197(6):711&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193846</ArticleId><ArticleId IdType="pubmed">12642603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC. Towards new avenues in the management of lupus glomerulonephritis. Nature reviews Rheumatology. 2016;12(4):221&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26729459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nature reviews Rheumatology. 2016;12(12):716&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">21785456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira S, Rosowski EE, Huttenlocher A. Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol. 2016;16(6):378&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367630</ArticleId><ArticleId IdType="pubmed">27231052</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010;330(6002):362&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20947763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843437</ArticleId><ArticleId IdType="pubmed">20203610</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, Al-Mohanna FA. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). Journal of leukocyte biology. 2002;71(3):433&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867681</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, Cepika AM, Acs P, Turner J, Anguiano E, Vinod P, Kahn S, Obermoser G, Blankenship D, Wakeland E, Nassi L, Gotte A, Punaro M, Liu YJ, Banchereau J, Rossello-Urgell J, Wright T, Pascual V. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell. 2016;165(3):551&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426482</ArticleId><ArticleId IdType="pubmed">27040498</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessenbrock K, Krumbholz M, Sch&#xf6;nermarck U, Back W, Gross WL, Werb Z, Gr&#xf6;ne HJ, Brinkmann V, Jenne DE. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760083</ArticleId><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727661</ArticleId><ArticleId IdType="pubmed">23536012</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorst A, Daniel C, Rzepka R, Sehnert B, Nimmerjahn F, Voll RE, Chevalier N. Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases. International journal of molecular sciences. 2019;20(13).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6651235</ArticleId><ArticleId IdType="pubmed">31266174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW, Park KH, Park S, Kim JH, Hong SY, Lee SK, Choi D, Park YB. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice. Arthritis and rheumatism. 2013;65(7):1902&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">23553192</ArticleId></ArticleIdList></Reference><Reference><Citation>Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Toure F. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice. J Immunol. 2015;194(8):3612&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">25762779</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356(6367):314&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">1372394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata S, Golstein P. The Fas death factor. Science. 1995;267(5203):1449&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">7533326</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes. 2006;55(9):2510&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16936199</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney international. 1984;25(4):689&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">6482173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature methods. 2012;9(7):671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J. Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice. Molecular therapy Methods &amp; clinical development. 2017;6:31&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472134</ArticleId><ArticleId IdType="pubmed">28649578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kezic S, O&#x2019;Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, Caspers P, Kemperman PM, Puppels GJ, Sandilands A, Chen H, Campbell LE, Kroboth K, Watson R, Fallon PG, McLean WH, Irvine AD. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. The Journal of allergy and clinical immunology. 2012;129(4):1031&#x2013;9 e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627959</ArticleId><ArticleId IdType="pubmed">22322004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner RM, Nyland JF, Silva IA, Ventura AM, de Souza JM, Silbergeld EK. Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environmental research. 2010;110(4):345&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873228</ArticleId><ArticleId IdType="pubmed">20176347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno Y, Ishii M, Yahagi K, Mano Y, Kisara N, Nakamura N, Shimosegawa T, Toyota T, Nagata S. Fas-mediated cholangiopathy in the murine model of graft versus host disease. Hepatology. 2000;31(4):966&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">10733554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, Bierhaus A, Lotze MT, Zeh HJ. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell death and differentiation. 2010;17(4):666&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3417122</ArticleId><ArticleId IdType="pubmed">19834494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou K, Liu W, Han D, Li P. HMGB1/RAGE axis promotes autophagy and protects keratinocytes from ultraviolet radiation-induced cell death. Journal of dermatological science. 2017;85(3):162&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28012822</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, Wang T, Zhu H, Zhang P, Han R, Liu Y, Ni P, Shen H, Xu W, Xu H. HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion. Immunobiology. 2015;220(5):539&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">25578401</ArticleId></ArticleIdList></Reference><Reference><Citation>Elouaai F, Lul&#xe9; J, Benoist H, Appolinaire-Pilipenko S, Atanassov C, Muller S, Fourni&#xe9; GJ. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB x NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol Dial Transplant. 1994;9(4):362&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8084447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Kanai Y, Kubota T. The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice. Journal of medical and dental sciences. 2003;50(1):9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12715914</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148(5):1198&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2185049</ArticleId><ArticleId IdType="pubmed">309911</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D&#x2019;Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, No&#xeb;l LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney international. 2018;93(4):789&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">29459092</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019;31(6):682&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812494</ArticleId><ArticleId IdType="pubmed">31389814</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittman K, Kubes P. Damage-associated molecular patterns control neutrophil recruitment. Journal of innate immunity. 2013;5(4):315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741494</ArticleId><ArticleId IdType="pubmed">23486162</ArticleId></ArticleIdList></Reference><Reference><Citation>Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010;120(7):2423&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898597</ArticleId><ArticleId IdType="pubmed">20516641</ArticleId></ArticleIdList></Reference><Reference><Citation>Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, Loike JD, Jenkins RE, Antoine DJ, Schwabe RF. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest. 2015;125(2):539&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4319429</ArticleId><ArticleId IdType="pubmed">25562324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold K, Xu Y, Sparkenbaugh EM, Li M, Han X, Zhang X, Xia K, Piegore M, Zhang F, Zhang X, Henderson M, Pagadala V, Su G, Tan L, Park PW, Stravitz RT, Key NS, Linhardt RJ, Pawlinski R, Xu D, Liu J. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Sci Transl Med. 2020;12(535).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315409</ArticleId><ArticleId IdType="pubmed">32188725</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Ong CY, Langou&#xeb;t-Astri&#xe9; CJ, Tan L, Verma A, Yang Y, Zhang X, Shah DK, Schmidt EP, Xu D. Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE. eLife. 2022;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863369</ArticleId><ArticleId IdType="pubmed">35137686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson PJ, Lokuta MA, El-Shanti HI, Muhle L, Bing X, Huttenlocher A. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis and rheumatism. 2008;58(10):3264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590197</ArticleId><ArticleId IdType="pubmed">18821685</ArticleId></ArticleIdList></Reference><Reference><Citation>Glennon-Alty L, Hackett AP, Chapman EA, Wright HL. Neutrophils and redox stress in the pathogenesis of autoimmune disease. Free radical biology &amp; medicine. 2018;125:25&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis and rheumatism. 1986;29(11):1334&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">2430586</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A, F&#xfc;rnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2906830</ArticleId><ArticleId IdType="pubmed">20439745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, Pittet JF, Tracey K, Thannickal VJ, Abraham E, Zmijewski JW. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol. 2013;304(5):L342&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3602738</ArticleId><ArticleId IdType="pubmed">23316068</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, Wang S, Kim J, Billiar T, Wang Y, Tsung A. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology. 2015;62(2):600&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4515210</ArticleId><ArticleId IdType="pubmed">25855125</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, McCune WJ, Kaplan MJ. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol. 2010;184(6):3284&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929645</ArticleId><ArticleId IdType="pubmed">20164424</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley A, Beresford MW. Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. Lupus. 2016;25(4):407&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26453665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Nakabo S, O&#x2019;Neil L, Goel RR, Jiang K, Carmona-Rivera C, Gupta S, Chan DW, Carlucci PM, Wang X, Naz F, Manna Z, Dey A, Mehta NN, Hasni S, Dell&#x2019;Orso S, Gutierrez-Cruz G, Sun HW, Kaplan MJ. Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2019;116(50):25222&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6911190</ArticleId><ArticleId IdType="pubmed">31754025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsiy O, de Carvalho Oliveira V, Mosha HT, McDonald PP. Early and Late Processes Driving NET Formation, and the Autocrine/Paracrine Role of Endogenous RAGE Ligands. Front Immunol. 2021;12:675315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8488397</ArticleId><ArticleId IdType="pubmed">34616390</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, Maiuri L, Maseri A, D&#x2019;Angelo A, Bianchi ME, Rovere-Querini P, Manfredi AA. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. Journal of thrombosis and haemostasis : JTH. 2014;12(12):2074&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">25163512</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Philippi V, Stockhausen S, Busse J, Antonelli A, Miller M, Schubert I, Hoseinpour P, Chandraratne S, von Br&#xfc;hl ML, Gaertner F, Lorenz M, Agresti A, Coletti R, Antoine DJ, Heermann R, Jung K, Reese S, Laitinen I, Schwaiger M, Walch A, Sperandio M, Nawroth PP, Reinhardt C, J&#xe4;ckel S, Bianchi ME, Massberg S. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood. 2016;128(20):2435&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5147023</ArticleId><ArticleId IdType="pubmed">27574188</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011;3(73):73ra20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3143837</ArticleId><ArticleId IdType="pubmed">21389264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pati&#xf1;o-Trives AM, P&#xe9;rez-S&#xe1;nchez C, P&#xe9;rez-S&#xe1;nchez L, Luque-T&#xe9;var M, &#xc1;balos-Aguilera MC, Alcaide-Ruggiero L, Arias-de la Rosa I, Rom&#xe1;n-Rodr&#xed;guez C, Segu&#xed; P, Espinosa M, Font P, Barbarroja N, Escudero-Contreras A, Antonio Gonz&#xe1;lez-Reyes J, Manuel Villalba J, Collantes-Est&#xe9;vez E, Aguirre-Zamorano M, L&#xf3;pez-Pedrera C. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arterioscler Thromb Vasc Biol. 2021;41(9):2417&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34320837</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima Y, Harashima A, Munesue S, Kimura K, Leerach N, Goto H, Tanaka M, Niimura A, Hayashi K, Yamamoto H, Higashida H, Yamamoto Y. Dual Nature of RAGE in Host Reaction and Nurturing the Mother-Infant Bond. International journal of molecular sciences. 2022;23(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8880422</ArticleId><ArticleId IdType="pubmed">35216202</ArticleId></ArticleIdList></Reference><Reference><Citation>Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984;133(1):227&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">6609979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley VE, Roths JB. Interaction of mutant lpr gene with background strain influences renal disease. Clinical immunology and immunopathology. 1985;37(2):220&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">4042431</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JS, Subramanian V, O&#x2019;Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Annals of the rheumatic diseases. 2015;74(12):2199&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320672</ArticleId><ArticleId IdType="pubmed">25104775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D, Kudo T. Novel Therapeutic Strategy Based on Neutrophil Subset and Its Function in Autoimmune Disease. Frontiers in pharmacology. 2021;12:684886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215496</ArticleId><ArticleId IdType="pubmed">34163363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>